News & Events NewsPress Releases In the Code Blog In the News Media Kit Press Releases February 26, 2024 Encoded Therapeutics Announces UK CTA Approval for Dravet Syndrome Gene Therapy Candidate ETX101 February 06, 2024 Encoded Therapeutics Announces US IND Clearance and Australian CTA Approval for Dravet Syndrome Gene Therapy Candidate ETX101 May 19, 2023 Encoded Therapeutics Addresses Common Source of Gene Therapy Toxicity While Achieving Precise Brain Expression in Non-Human Primates, Presented at the American Society of Gene and Cell Therapy 26th Annual Meeting View All Press Releases In the Code Blog October 24, 2023 Our platform to discover and validate regulatory elements to drive targeted transgene expression for use in gene therapies Read Full Article October 13, 2022 Building Customized Gene Expression Profiles Read Full Article September 20, 2022 Right-Sized in RTP: Building Out Encoded’s Manufacturing Ecosystem Read Full Article View All Blog Articles In the News June 13, 2022 Gene therapy targets interneurons to tackle Dravet syndrome Spectrum May 12, 2022 Gene Therapy’s Commercial Manufacturing Issues — With Encoded Therapeutics’ Andy Stober Cell and Gene Podcast August 10, 2021 Activating SCN1A to Treat Dravet Syndrome GeneTherapyLive View All News Stories Media Kit Logo Leadership Photos Kartik Ramamoorthi, Ph.D. Encoded Co-Founder, CEO and Board Member Stephanie Tagliatela Encoded Co-Founder, Chief Scientific Officer and Board Member Salvador Rico, M.D., Ph.D. Encoded Chief Medical Officer Photos Encoded lab coat Encoded Therapeutics headquarters in South San Francisco Scientists in Encoded’s sequencing lab Scientist in Encoded’s lab Scientist in Encoded’s lab Scientist in Encoded’s lab Download Photo Archive Video Footage